Vulnerability in Philips Intellivue Mp2-Mp90

CVE-2020-16228

In Patient Information Center iX (PICiX) Versions C.02 and C.03, PerformanceBridge Focal Point Version A.01, IntelliVue patient monitors MX100, MX400-MX550, MX750, MX850, and IntelliVue X3 Versions N and prior, the software does not check or incorrectly checks the revocation status of a certificate, which may cause it to use a compromised certificate.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 6.4 (Medium). Vector: CVSS:3.1/AV:A/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:L.

EPSS exploit prediction

EPSS: 0.004 (29.2th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 29th percentile — 29.2% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2020-16228: held from 0.004 to 0.004.

EPSS over last 30 days · oldest: 0.004 · newest: 0.004 · change: 0.000

Affected products

Weakness classification (CWE)

Public proof-of-concept exploits

References

Frequently asked questions

What is CVE-2020-16228?
CVE-2020-16228 is a medium-severity vulnerability in Philips Intellivue Mp2-Mp90, classified under Improper Check for Certificate Revocation. CVSS score: 6.4/10. Published 2020-09-11.
How severe is CVE-2020-16228?
Medium severity. CVSS v3 base score is 6.4 out of 10.
Is CVE-2020-16228 known to be exploited?
1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.